Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions

Journal of Neuroimmunology

Volumn 99, Issue 2, 1999, Pages 169-172

  Losy, Jacek ^a,b   Niezgoda, Adam ^a   Wender, Mieczysław ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Inst Ctr Exp Clin Med Pol A   (Poland)

Author keywords

Adhesion molecules; Multiple sclerosis; sPECAM 1

Indexed keywords

CD31 ANTIGEN; CELL ADHESION MOLECULE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; GLYCOPROTEIN;

ARTICLE; CELL ADHESION; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; IMMUNOMODULATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE MIGRATION; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD31; CELL MOVEMENT; CONTRAST MEDIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GADOLINIUM DTPA; HUMANS; LYMPHOCYTES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SOLUBILITY;

EID: 0032705907     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00092-2     Document Type: Article

References (24)

1. Albelda S.M., Müller W.A., Buck C.A., Newman P.J. Molecular and cellular properties of PECAM-1. A novel vascular cell-cell adhesion molecule. J. Cell Biol. 114:1991;1059-1068.
2. Bevilacqua M.P. Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11:1993;767-804.
3. Bogen S.J., Pak J., Gavifallon M., Deng X., Müller W.A. Monoclonal antibody to murine PECAM-1 (CD31) blocks acute inflammation in vivo. J. Exp. Med. 179:1994;1059-1064.
4. Buckley C., Doyonnas R., Newton J.P., Blystone S.D., Brown E.J., Watt S.M., Simmons D.L. Identification of alpha v beta 3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109:1996;437-445.
5. Dore-Duffy P., Newman W., Balabanov R., Lisak R.P., Mainolfi E., Rothlein R., Peterson M. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann. Neurol. 37:1995;55-62.
6. Fawcett J.C., Buckley C., Holness C.D., Bird I.N., Spragg J.H., Saunders J., Harris A., Simmons D.L. Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of inter-endothelial cell contacts. J. Cell Biol. 128:1995;1229-1241.
7. Fureder W., Agis H., Sperr W.R., Lechner K., Valent P. The surface membrane antigen phenotype of human blood basophils. Allergy. 49:1994;861-865.
8. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol. Today. 14:1993;506-512.
9. Goldberger A., Middleton K.A., Oliver J.A., Paddock C., Yan H.C., DeLisser H.M., Albelda S.M., Newman P.J. Biosynthesis and processing of the v cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem. 269:1994;17183-17191.
10. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
11. Link H., Tibbling G. Principles of albumin and IgG analysis in neurological disorders: III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 37:1977;397-401.
12. Mehta P., Patrick B., Black J. Detection of oligoclonal IgG bands in unconcentrated CSF by isoelectric focusing in agarose and solver staining. J. Neurosci. Meth. 16:1989;277-282.
13. Mößner R., Fassbender K., Kühnen J., Schwartz A., Hennerici M. Circulating L-selectin in multiple sclerosis patients with active, gadolinium-enhancing brain plaques. J. Neuroimmunol. 65:1996;61-65.
14. Müller W.A., Ratti C.M., McDonell S.L., Cohn Z.A. A human endothelial cell-restricted externally disposed plasma lemmal protein enriched in intercellular junctions. J. Exp. Med. 170:1989;399-414.
15. Müller W.A., Weigl S.A., Deng X., Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:1993;449-460.
16. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 100:1997;25-29.
17. Piali L., Albelda S.M., Baldwin H.S., Hammel P., Gisler R.H., Imhof B. Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates beta 2 integrins on lymphokine-activated killer cells. Eur. J. Immunol. 23:1993;2464-2471.
18. Piali L., Hammel P., Uherek C., Bachmann F., Gisler R.H., Dunon D., Imhof B.A. CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium. J. Cell. Biol. 130:1995;451-460.
19. Poser C.M., Paty D.W., Scheiberg L. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
20. Rieckman P., Altenhofen B., Riegel A., Baudewig J., Felgenhauer K. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis. Ann. Neurol. 41:1997;326-333.
21. Tanaka Y., Albelda S.M., Horgan K.J., van Seventer G.A., Shimizu Y., Newman W., Hallam J., Newman P.J., Buck C.A., Shaw S. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J. Exp. Med. 176:1992;245-253.
22. Vaporciyan A., DeLisser H.M., Yan H.C., Mendiguren I.I., Thorn S.R., Jones M., Ward P.A., Albelda S.M. Involvement of PECAM-1 in neutrophil recruitment in vivo. Science. 262:1993;1580-1582.
23. Varon D., Jackson D.E., Shenkman B., Dardik R., Tamarin I., Savion N., Newman P.J. Platelet/endothelial cell adhesion molecule-1 serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood. 91:1998;500-507.
24. Wakelin M.W., Sanz M.J., Dewar A., Albelda S.M., Larkin S.W., Boughton-Smith N., Williams T.J., Nourshargh S. An anti-platelet-endothelial cell adhesion molecule-1 antibody inhibits leukocyte extravasation from mesenteric microvessels in vivo by blocking the passage through the basement membrane. J. Exp. Med. 184:1996;229-239.